Peripheral Myelin Protein-22 and Its Prominence in Charcot-Marie-Tooth Disease
Open Access
- 20 May 2026
- journal article
- review article
- Published by American Chemical Society (ACS) in Chemical Reviews
- Vol. 126 (12) , 7165-7206
Abstract
Charcot-Marie-Tooth disease (CMT) is an often-debilitating peripheral neuropathy that is a top-10 most prevalent human genetic disorder. However, there is currently no effective treatment. Over half of diagnosed CMT cases in western populations are caused by genetic variations that alter the expression levels or sequence of peripheral myelin protein 22 (PMP22). PMP22 is a tetraspan membrane glycoprotein that is most highly expressed in Schwann cells (SCs) of the peripheral nervous system (PNS) under conditions of myelination, where it plays multiple important roles. These functions are reduced in humans with only a single PMP22 allele, resulting in a common and usually mild form of CMT, hereditary neuropathy with liability to pressure palsies (HNPP). The rare type 1E CMT (CMT1E) is caused by amino acid variations in PMP22. The most common form of CMT (CMT1A) is caused by a third wild type (WT) allele of PMP22. The disease mechanisms of CMT1A are still incompletely understood, but there is much evidence that a major driver is proteostasis stress caused by WT PMP22 overexpression upon induction of myelination in SCs, possibly compounded by gain-of-function effects. Here, we explore PMP22's structure, functions, trafficking, role in CMT, and prospects for successful therapeutic intervention.Keywords
Funding Information
- National Institute of Neurological Disorders and Stroke (R01 NS095989)
- CMT Research Foundation
This publication has 461 references indexed in Scilit:
- Neuropathy in a Human Without the PMP22 GeneArchives of Neurology, 2011
- Altered molecular architecture of peripheral nerves in mice lacking the peripheral myelin protein 22 or connexin32Journal of Neuroscience Research, 1999
- Localization and functional roles of PMP22 in peripheral nerves of P0-deficient miceGlia, 1999
- Temporal expression pattern of peripheral myelin protein 22 during in vivo and in vitro myelinationGlia, 1999
- Major histocompatibility complex class II expression and macrophage responses in genetically proven Charcot-Marie-Tooth type 1 and hereditary neuropathy with liability to pressure palsiesMuscle & Nerve, 1998
- Clinical and pathological correlations in charcot-marie-tooth neuropathy type 1A with the 17p11.2p12 duplication: A cross-sectional morphometric and immunohistochemical study in twenty casesMuscle & Nerve, 1998
- Improved culture methods to expand schwann cells with altered growth behaviour from CMT1A patientsGlia, 1998
- Many facets of the peripheral myelin protein PMP22 in myelination and diseaseMicroscopy Research and Technique, 1998
- Molecular bases of myelin formation as revealed by investigations on mice deficient in glial cell surface moleculesGlia, 1997
- Studies on the effects of altered PMP22 expression during myelination in vitroJournal of Neuroscience Research, 1997